Brca1 And Brca2 Gene Sequencing Panel

DESCRIPTION – identifies mutation in gene ½ leading to hereditary breast cancer. Detects point mutation in the sequence and small indel mutations

TEST CODE – NA1030

METHODOLOGY – next generation sequencing (NGS)

TURN AROUND TIME – 15 days

PATIENT PREPARATION –

COLLECT – lavender or pink (EDTA) or yellow (ACD solution A or B)

SPECIMEN PREPARATION – 3-4 ml bone marrow or peripheral blood

STORAGE/TRANSPORT TEMPERATURE – 2-8 degrees C (with cold pack)

STABILITY – ambient: 72 hours; refrigerated: 1 week

UNACCEPTABLE CONDITIONS – serum or plasma, clotted or frozen specimen, saliva, buccal brush or swab

MRP – 20000

SPECIAL INSTRUCTIONS – clinical history, biopsy, ER/PR, HER2 neu reports are mandatory